Sulphonamides market in Germany

Earlier Report Observations

From 2018 to 2020, the German sulphonamides market volume contracted from 5 466 t to 4 725 t. This decline was driven by a substantial fall in imports, which dropped from 6 122 t to 5 255 t, even as domestic production rose slightly from 1 116 t to 1 197 t.

Starting in 2021, imports rebounded and grew consistently, reaching 7 051 t by 2024. This expansion was fueled by rising antibiotic resistance and the growing prevalence of chronic diseases, which increased demand. Major pharmaceutical firms, including GlaxoSmithKline, Pfizer, and Roche, boosted investments in research and development for new sulphonamide combination therapies. From 2022 onward, greater awareness of the drugs' efficacy, higher prescription rates, and an aging population further supported import growth, while the market adapted to global supply chain disruptions and EU regulatory shifts.

Production sulphonamides in Germany

In value, 2017-2020, M $ US

Germany's sulphonamides production has increased for the third consecutive year. In 2020, output was valued at 119.9 million US dollars, marking a modest 7.0% rise from 2019. Over the period from 2017 to 2020, production grew by 20.4%, with a compound annual growth rate of 6.4%.

Annual dynamics of production in Germany in value, 2017-2020, M $ US

In kind, 2017-2020, t

Germany's sulphonamides production volume has risen for the third year in a row. In 2020, the country produced 1 197 tonnes, which is 6.0% higher than the previous year. Between 2017 and 2020, production increased by 28.6%, translating to an annualized growth rate of 8.7%.

Annual dynamics of production in Germany in kind, 2017-2020, t

Exports sulphonamides from Germany

Exports in kind, t

After two years of growth, Germany's sulphonamides export volume declined. In 2020, exports reached 1 726 tonnes, representing a significant 10.5% drop compared to 2019. Over the 2017-2020 period, exports increased by 6.3%, with an annualized rate of 2.1%. The highest volume was recorded in 2019 at 1 929 tonnes, while the largest increase occurred in 2018 at 9.1%.

Annual dynamics of product's exports from Germany in kind, 2017-2020, t

From 2017 to 2020, France, the United States, and the Netherlands were the primary markets for Germany's sulphonamides exports in volume terms, accounting for 27.0%, 16.4%, and 7.3% of exports, respectively. Together, they made up 50.7% of total export flows.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Germany in kind, 2017-2020

Exports in value, M $ US

Germany's sulphonamides exports have declined for the third consecutive year. In 2020, export value stood at 137 million US dollars, showing a gradual decrease of 9.6% from 2019. Between 2017 and 2020, exports fell by 24.4%, with a compound annual decline rate of 8.9%.

Annual dynamics of product's exports from Germany in value, 2017-2020, M $ US

During 2017-2020, Germany's sulphonamides exports in value terms were distributed across numerous markets. France, the United States, and Ireland accounted for 19.7%, 17.7%, and 6.8% of exports, respectively, totaling 44.3% of overall flows.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Germany in value, 2017-2020

Imports sulphonamides to Germany

Imports in kind, t

Germany's sulphonamides import volume has decreased for the second year in a row. In 2020, imports totaled 5 255 tonnes, reflecting a modest 9.4% decline from the previous year. Over the 2017-2020 period, imports dropped by 14.2%, with a compound annual decrease of 5.0%. The largest increase was recorded in 2018 at 0.0%.

Annual dynamics of product's imports to Germany in kind, 2017-2020, t

From 2017 to 2020, India, China, and Switzerland were the key sources for Germany's sulphonamides imports in volume terms, representing 33.0%, 13.4%, and 11.1% of imports, respectively. Combined, they accounted for 57.5% of total import flows.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Germany in kind, 2017-2020

Imports in value, M $ US

The market exhibited volatility during the observed period. Imports peaked in 2018 at 4 587 million US dollars and reached their lowest point in 2020, with a 9.3-fold difference between these years. In 2020, Germany imported sulphonamides valued at 4 587 million US dollars, indicating a limited 5.9% loss compared to the previous year. The largest decline occurred in 2019 at 88.6%, while the largest increase was in 2018 at 156.2%.

Annual dynamics of product's imports to Germany in value, 2017-2020, M $ US

Between 2017 and 2020, Italy, Singapore, and Ireland were the main destinations for sulphonamides imports to Germany in value terms, accounting for 44.1%, 34.9%, and 7.6% of imports, respectively. Together, they made up 86.6% of total import flows.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Germany in value, 2017-2020